Crestline Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zions Bancorporation
ZION
|
+$14.2M |
| 2 |
M&T Bank
MTB
|
+$10.2M |
| 3 |
NCR Voyix
VYX
|
+$9.56M |
| 4 |
8x8 Inc
EGHT
|
+$8.53M |
| 5 |
Aon
AON
|
+$8.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
American International
AIG
|
+$10.5M |
| 2 |
FITB
Fifth Third Bancorp
FITB
|
+$9.88M |
| 3 |
Enovis
ENOV
|
+$8.75M |
| 4 |
Goodyear
GT
|
+$7.54M |
| 5 |
JPMorgan Chase
JPM
|
+$6.57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.09% |
| 2 | Financials | 24.28% |
| 3 | Technology | 12.27% |
| 4 | Industrials | 8.46% |
| 5 | Materials | 8.06% |
Similar funds
Crestline Management's Q2 2022 Portfolio in Review
As of Q2 2022, Crestline Management held 345 positions worth $766M, down 8.1% from $834M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Crestline Management deployed $38.7M of net new capital in Q2 2022, opening 89 new positions and adding to 60 existing holdings. Its largest new stake was Zions Bancorporation: 250,000 shares worth $12.7M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Ameriprise Financial, an estimated $4.18M trimmed.
- Crestline Management's largest Q2 2022 buy was Zions Bancorporation: 250,000 shares worth $12.7M.
- Crestline Management added most to M&T Bank in Q2 2022, an estimated $10.2M increase.
- Crestline Management's biggest Q2 2022 reduction was Ameriprise Financial, cutting an estimated $4.18M.
- Crestline Management fully exited American International in Q2 2022, selling an estimated $10.5M.
- Crestline Management's ten largest holdings make up 43% of its $766M portfolio in Q2 2022.
- Crestline Management opened 89 new positions and closed 124 in Q2 2022.
- Crestline Management's portfolio value fell 8.1% quarter-over-quarter to $766M.
Based on Crestline Management's 13F filing for Q2 2022, filed 12 Aug 2022.